Showing results (31-40 of 90) with videos related to
Sort By:
Pageof 9
Oncogene|June 10, 1998
Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivityG S Wu, P Saftig, C Peters, et al.Biochemical and Biophysical Research Communications|October 14, 1996
Proteasome-dependent regulation of p21WAF1/CIP1 expressionM V Blagosklonny, G S Wu, S Omura, et al.Digestion|October 31, 2001
Pioglitazone inhibits growth of carcinoid cells and promotes TRAIL-induced apoptosis by induction of p21waf1/cip1R Göke, A Göke, B Göke, et al.Cancer Research|May 15, 1996
Repair Defect in p21 WAF1/CIP1 -/- human cancer cellsE R McDonald, G S Wu, T Waldman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Molecular determinants of response to TRAIL in killing of normal and cancer cellsK Kim, M J Fisher, S Q Xu, et al.Biochemical and Biophysical Research Communications|November 2, 1999
Comparative gene expression profiling in response to p53 in a human lung cancer cell lineS Song, T K MacLachlan, R D Meng, et al.International Journal of Oncology|June 19, 1998
p73beta, unlike p53, suppresses growth and induces apoptosis of human papillomavirus E6-expressing cancer cellsN S Prabhu, K Somasundaram, K Satyamoorthy, et al.The Journal of Biological Chemistry|July 8, 2000
Repression of BRCA1 through a feedback loop involving p53T K MacLachlan, B C Dash, D T Dicker, et al.International Journal of Oncology|February 15, 2001
Enhanced TRAIL sensitivity by p53 overexpression in human cancer but not normal cell linesK Kim, R Takimoto, D T Dicker, et al.Nature Genetics|April 1, 1992
Definition of a consensus binding site for p53W S el-Deiry, S E Kern, J A Pietenpol, et al.Pageof 9